Advancing Prostate Cancer Imaging: The Role of Micro-Ultrasound

Have you ever wondered what it feels like to personally talk with leading KOLs? Now is your chance!
The "One On One" format features immediate unscripted dialogue, and rapid-fire question-and-answer exchange between the audience and the KOL, as if you were having a face-to-face meeting.
Don't lose this opportunity!

Dr. Hannes Cash began his medical career as a Resident Doctor at the Clinic for Urology, Charité – Universitätsmedizin Berlin, working under Prof. Dr. K. Miller from 2009 to 2014. Following this, he specialized in Urology at the same clinic until 2016. In 2014 and 2015, he served as a Visiting Scientist at the Max Planck Institute of Molecular Genetics, Core Sequencing Facility in Berlin, funded by the Eisenberger Scholarship of the German Society of Urology (DGU).

In 2017, Dr. Cash achieved his Habilitation with a focus on the implications of MRI/ultrasound fusion-guided targeted biopsies on the diagnostics of prostate cancer, earning Venia Legendi for the subject Urology at Charité – Universitätsmedizin Berlin. He continued his career as a Senior Physician at the Clinic for Urology, Charité, before taking on the role of Coordinator of the Prostate Cancer Center from 2016 to 2020.

From 2018 to September 2020, Dr. Cash served as the head of BPH laser therapy and imaging of the prostate, fusion biopsy, and focal therapy at the Clinic for Urology, Charité – Universitätsmedizin Berlin, under Prof. Dr. T. Schlomm.

In 2018, Dr. Cash’s group was the first to use 29 MHz high-resolution micro-ultrasound for the diagnostics of prostate cancer in Germany, and the group was among the first to publish data on the potential of this novel imaging modality.

In June 2020, Dr. Cash and Dr. Buckendahl founded the specialized practice ProUro Berlin in cooperation with MEOCLINIC.

The clinical focus is GreenLight laser treatment of benign prostatic hyperplasia (BPH), minimally invasive treatment of BPH with the REZÜM system, MRI, ultrasound fusion biopsy using micro-ultrasound.

Dr. Cash was involved in both planning and as local PI of the OPTIMUM trial comparing micro-ultrasound to MRI for prostate cancer detection, which was just published in JAMA.